Trine Bartholdy

Trine Bartholdy has a diverse work experience spanning over several industries. Trine has held senior leadership positions in various organizations, including BioInnovation Institute, where they currently serve as the Chief Innovation Officer. Trine has also worked as the Chief Executive Officer at The Fertility Partnership and has been a Member of the Board of Directors at Forendo Pharma Ltd. Trine has demonstrated their expertise in the life sciences sector through their roles as an Investment Director at Sunstone Capital and Danish Growth Fund. Trine has also gained experience in private equity and venture capital at Danske Markets. Earlier in their career, they worked on private sector development projects in international consulting at Ramboll. Trine's work history showcases their strategic leadership and business development skills in diverse industries.

Trine Bartholdy has a comprehensive education history which includes various degrees and specializations. In 1987, they obtained a Studentereksamen with a focus on Natural Science and Mathematics from Holte Gymnasium. This was followed by a Bachelor's degree in Business/Economics from Copenhagen Business School, which they completed from 1989 to 1995. Trine then pursued their Master of Science in Finance from Copenhagen Business School between 1995 and 1998. In the same period, they also gained a MSc. in Finance from Universidad Autónoma de Madrid. Later, from 2009 to 2011, Trine pursued a post-graduate course in the Development of Pharmaceutical Medicine at the European Center of Pharmaceutical Medicine (ECPM). In 2022, they further enhanced their knowledge by completing a course in Board Work in Industrial Foundation (Bestyrelsesarbejde i Erhvervsfonde) at CBS Executive Fonden.